3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Rectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Head and Neck Neoplasms
4
Glioblastoma
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Recurrence
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Wilms Tumor
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Interventions
Gemcitabine
31
pembrolizumab
20
Cisplatin
20
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
11
Mitomycin
11
enfortumab vedotin
9
avelumab
9
Nivolumab
9
Cystoscopy
9
Fluorouracil
8
Radiation
7
Carboplatin
7
Radiotherapy
6
Immunoglobulin G
6
Docetaxel
6
Disulfides
6
Cystectomy
6
Transurethral Resection of Bladder
5
Mitozytrex
5
Biopsy
5
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
atezolizumab
4
Standard of Care
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
tremelimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.